Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Role of ketogenic metabolic therapy in malignant glioma: A systematic review.

Winter SF, Loebel F, Dietrich J.

Crit Rev Oncol Hematol. 2017 Apr;112:41-58. doi: 10.1016/j.critrevonc.2017.02.016. Epub 2017 Feb 20. Review.

PMID:
28325264
2.

The ketogenic diet for the treatment of malignant glioma.

Woolf EC, Scheck AC.

J Lipid Res. 2015 Jan;56(1):5-10. doi: 10.1194/jlr.R046797. Epub 2014 Feb 6. Review.

3.

Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy.

Maurer GD, Brucker DP, Bähr O, Harter PN, Hattingen E, Walenta S, Mueller-Klieser W, Steinbach JP, Rieger J.

BMC Cancer. 2011 Jul 26;11:315. doi: 10.1186/1471-2407-11-315.

4.

Ketogenic diet and other dietary treatments for epilepsy.

Martin K, Jackson CF, Levy RG, Cooper PN.

Cochrane Database Syst Rev. 2016 Feb 9;2:CD001903. doi: 10.1002/14651858.CD001903.pub3. Review.

PMID:
26859528
5.

Metabolic therapy: a new paradigm for managing malignant brain cancer.

Seyfried TN, Flores R, Poff AM, D'Agostino DP, Mukherjee P.

Cancer Lett. 2015 Jan 28;356(2 Pt A):289-300. doi: 10.1016/j.canlet.2014.07.015. Epub 2014 Jul 25. Review.

PMID:
25069036
6.

Gliadel wafers in the treatment of malignant glioma: a systematic review.

Perry J, Chambers A, Spithoff K, Laperriere N.

Curr Oncol. 2007 Oct;14(5):189-94.

7.

The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma.

Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC.

PLoS One. 2012;7(5):e36197. doi: 10.1371/journal.pone.0036197. Epub 2012 May 1.

8.

Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma.

Poff A, Koutnik AP, Egan KM, Sahebjam S, D'Agostino D, Kumar NB.

Semin Cancer Biol. 2017 Dec 30. pii: S1044-579X(17)30124-4. doi: 10.1016/j.semcancer.2017.12.011. [Epub ahead of print] Review.

PMID:
29294371
9.

Interventions for central serous chorioretinopathy: a network meta-analysis.

Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P.

Cochrane Database Syst Rev. 2015 Dec 22;(12):CD011841. doi: 10.1002/14651858.CD011841.pub2. Review.

10.

The ketogenic diet for the treatment of glioma: insights from genetic profiling.

Scheck AC, Abdelwahab MG, Fenton KE, Stafford P.

Epilepsy Res. 2012 Jul;100(3):327-37. doi: 10.1016/j.eplepsyres.2011.09.022. Epub 2011 Oct 22. Review.

PMID:
22019313
11.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review.

PMID:
25242542
12.

Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature.

Schwartz K, Chang HT, Nikolai M, Pernicone J, Rhee S, Olson K, Kurniali PC, Hord NG, Noel M.

Cancer Metab. 2015 Mar 25;3:3. doi: 10.1186/s40170-015-0129-1. eCollection 2015.

13.

The Ketogenic Diet Alters the Hypoxic Response and Affects Expression of Proteins Associated with Angiogenesis, Invasive Potential and Vascular Permeability in a Mouse Glioma Model.

Woolf EC, Curley KL, Liu Q, Turner GH, Charlton JA, Preul MC, Scheck AC.

PLoS One. 2015 Jun 17;10(6):e0130357. doi: 10.1371/journal.pone.0130357. eCollection 2015.

14.

Ketogenic diets: from cancer to mitochondrial diseases and beyond.

Branco AF, Ferreira A, Simões RF, Magalhães-Novais S, Zehowski C, Cope E, Silva AM, Pereira D, Sardão VA, Cunha-Oliveira T.

Eur J Clin Invest. 2016 Mar;46(3):285-98. doi: 10.1111/eci.12591. Review.

PMID:
26782788
15.

Ketogenic diet and other dietary treatments for epilepsy.

Levy RG, Cooper PN, Giri P.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD001903. doi: 10.1002/14651858.CD001903.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;2:CD001903.

PMID:
22419282
16.

Restricted calorie ketogenic diet for the treatment of glioblastoma multiforme.

Maroon J, Bost J, Amos A, Zuccoli G.

J Child Neurol. 2013 Aug;28(8):1002-8. doi: 10.1177/0883073813488670. Epub 2013 May 13. Review.

PMID:
23670248
17.

Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

Elsakka AMA, Bary MA, Abdelzaher E, Elnaggar M, Kalamian M, Mukherjee P, Seyfried TN.

Front Nutr. 2018 Mar 29;5:20. doi: 10.3389/fnut.2018.00020. eCollection 2018.

18.

The role of metabolic therapy in treating glioblastoma multiforme.

Maroon JC, Seyfried TN, Donohue JP, Bost J.

Surg Neurol Int. 2015 Apr 16;6:61. doi: 10.4103/2152-7806.155259. eCollection 2015.

19.

The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature.

Varshneya K, Carico C, Ortega A, Patil CG.

Cureus. 2015 Feb 27;7(2):e251. doi: 10.7759/cureus.251. eCollection 2015 Feb. Review.

20.

Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2010;10(27):1-118. Epub 2010 Dec 1.

Supplemental Content

Support Center